Document is current

Any future updates will be listed below

Correction to: Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT

Crossref DOI link: https://doi.org/10.1007/s12325-024-02886-x

Published Online: 2024-05-24

Published Print: 2024-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark